https://www.sesamers.com/funding/kasvu-therapeutics-raises-30m-series-a-depression-drug/ Sesamers en 2026-09-26T12:19:13+00:00 Kasvu Therapeutics raises €30M Series A for depression drug https://www.sesamers.com/funding/noxtua-raises-100m-series-c-ch-beck-majority/ Sesamers en 2026-09-26T09:20:16+00:00 Noxtua raises €100M+ Series C as C.H.BECK takes majority https://www.sesamers.com/funding/reecall-raises-3-5m-white-label-voice-ai/ Sesamers en 2026-09-26T06:10:32+00:00 Reecall raises €3.5M to sell white-label voice AI to software vendors https://www.sesamers.com/funding/wealthcome-raises-15m-series-b-wealth-management-software/ Sesamers en 2026-09-25T12:38:40+00:00 Wealthcome raises €15M Series B to equip France’s wealth advisers https://www.sesamers.com/funding/highlife-raises-90m-us-pivotal-study-mitral-valve/ Sesamers en 2026-09-25T09:19:07+00:00 HighLife raises $90M+ to start US pivotal study for its mitral valve https://www.sesamers.com/funding/kontext-raises-4m-seed-ai-agent-runtime-security/ Sesamers en 2026-09-25T06:14:27+00:00 Kontext raises $4M seed to police what AI agents actually do https://www.sesamers.com/funding/benford-raises-5m-pre-seed-tech-native-audit-firm/ Sesamers en 2026-09-24T15:16:21+00:00 Benford raises €5M pre-seed to run audits, not sell audit software